Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

69.82 -0.21 (-0.30%)
Official Closing Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,369,729
Open 70.07
Bid (Size) 69.68 (1)
Ask (Size) 70.01 (1)
Prev. Close 70.03
Today's Range 69.59 - 70.45
52wk Range 64.62 - 104.83
Shares Outstanding 1,319,574,744
Dividend Yield 2.86%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pharmacy Retailer Giant Walgreens Considers Former Cigna Exec For CEO Role
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly considering appointing Tim Wentworth, a former executive at Cigna Group (NYSE: CI), as its next CEO amid a search for leadership 
Via Benzinga
Some Economics Of Pharmacy Benefit Managers
It is a common belief, that if you could just “cut out the middleman” and “pass the savings along to consumers,” everyone would be better off. Pharmacy benefit managers are quintessential middlemen. 
Via Talk Markets

Performance

YTD
-24.85%
-24.85%
1 Month
+4.47%
+4.47%
3 Month
+1.00%
+1.00%
6 Month
-6.04%
-6.04%
1 Year
-28.01%
-28.01%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Retail Stocks to Sell Before the Damage Is Done
Via InvestorPlace
Cramer Shrugs Off Stock With Over 10% Yield: 'I Don't Want That Dividend, I Need Growth'
Via Benzinga
Looking At CVS Health's Recent Unusual Options Activity
Via Benzinga
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Expert Ratings for CVS Health
Via Benzinga
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Via MarketBeat
Global Consulting Firm McKinsey To Pay $230M In Opioid Lawsuit Settlements With US Local Governments
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Tuesday's Market Minute: Previewing Costco (COST) Earnings
Via Benzinga
3 Best Stocks to Buy in September and Hold Forever
Via The Motley Fool
CVS Health vs. Walgreens Boots Alliance: Which Is the Better Dividend Stock to Own?
Via The Motley Fool
CVS Health Corp. (NYSE: CVS) Highlighted for Surprising Price Action
Via Investor Brand Network
CVS Health Unusual Options Activity For September 19
Via Benzinga
A Look Into CVS Health Inc's Price Over Earnings
Via Benzinga
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
Via Benzinga
Exposures COVID-19
CVS Health Gains Momentum: Analyst Points To Potential 4-Star Medicare Rating
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Via Benzinga
2 Beaten-Down Dividend Growth Stocks That Look Like Bargains Now
Via The Motley Fool
3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them
Via The Motley Fool
Topics Stocks
Exposures US Equities
Stagflationary Moves In Bonds And Oil Opens Golden Opportunity
Via Talk Markets
Betting With the ‘Big Short’: 3 Michael Burry Stocks to Bank On
Via InvestorPlace
3 Strong Sell Stocks for September 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.